Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin in Cocaine Use Disorder
NCT06102434Phase 1Suspended
- Sponsor
- University of California, Los Angeles
- Start
- Feb 2029
- Primary completion
- May 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of psilocybin in cocaine use disorder (CUD), sponsored by University of California, Los Angeles. Primary endpoints: Heart rate at 6 hours, Blood pressure at 6 hours and 1 more. Planned start Feb 2029; status: suspended.
02
Drugs
psilocybin
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT06102434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06102434.